Market News & Trends
Ompi Presents its Integrated Needlestick Protection
Pharmapak Paris, February 1-2, 2017, Paris Expo, Porte de Versailles, Paris, France, Hall 4 Visit Ompi at Booth No. J5 & Balda at Booth No.…
Ompi Presents its Integrated Needlestick Protection
Pharmapak Paris, February 1-2, 2017, Paris Expo, Porte de Versailles, Paris, France, Hall 4 Visit Ompi at Booth No. J5 & Balda at Booth No.…
Vetter Starts Operations in its Center for Visual Inspection & Logistics
Vetter recently announced it has begun operations in its expanded Visual Inspection and Logics Center located in Ravensburg. The enlargement, in which the company invested…
TG Therapeutics Announces Orphan Drug Designation
TG Therapeutics, Inc. recently announced that the US FDA has granted orphan drug designation covering the combination of TG-1101 (ublituximab), the company's novel, glycoengineered anti-CD20…
scPharmaceuticals Announces Start of SUBQ-HF NHLBI Study
scPharmaceuticals, Inc. recently announced the start of the first phase of a study conducted by the Heart Failure Clinical Research Network (HFN). HFN is a…
Neovacs Reports First Positive Immunogenicity Results
Neovacs recently announced the recommendation of its Scientific Advisory Board to extend the development of IFN Kinoid to a new indication, Type 1 Diabetes, with…
Domain Therapeutics & Merck Enter License & Collaboration Agreement
Domain Therapeutics recently announced that a collaboration and licensing agreement with Merck has been signed for the development of adenosine receptor antagonist drugs specifically designed…
Aptose Prioritizes Development of First-in Class FLT3/BTK Inhibitor
Aptose Biosciences Inc. recently announced it will prioritize its resources toward the development of CG’806, an oral preclinical compound being developed for patients with FLT3-driven…
Terumo & Nemera Announce Validated Compatibility Between PLAJEX Polymer Prefillable Syringes & Safe'n'Sound
To serve the needs of the pharmaceutical industry and users, Nemera and Terumo agreed to cooperate to confirm compatibility between PLAJEXTM COP prefillable syringes and…
Mikron Automation Expands US Headquarters in Metro Denver
Mikron Automation and Denver-based Confluent Development are pleased to announce the expansion of Mikron Automation’s U.S. headquarters in Arapahoe County’s Dove Valley Business Park. The…
Mikron Automation Expands US Headquarters in Metro Denver
Mikron Automation and Denver-based Confluent Development are pleased to announce the expansion of Mikron Automation’s U.S. headquarters in Arapahoe County’s Dove Valley Business Park. The…
Antibacterial Drugs Market Will Hit $35.6 Billion by 2022
The antibacterial drugs market is set to grow from $27.7 billion in 2015 to $35.6 billion by 2022, representing a compound annual growth…
Antibacterial Drugs Market Will Hit $35.6 Billion by 2022
The antibacterial drugs market is set to grow from $27.7 billion in 2015 to $35.6 billion by 2022, representing a compound annual growth…
Adamis Announces NDA Resubmission of its Epinephrine Pre-Filled Syringe Application
Adamis Pharmaceuticals Corporation recently announced the resubmission of the company’s New Drug Application (NDA) to the US FDA for its Epinephrine Pre-filled Syringe (PFS) product…
Symbiomix Submits New Drug Application to US FDA
Symbiomix recently announced submission of a new drug application (NDA) for Solosec (secnidazole oral granules) for the treatment of bacterial vaginosis (BV) to the US…
Tetraphase Pharmaceuticals Doses First Patient in Phase III Trial
Tetraphase Pharmaceuticals, Inc. recently announced dosing of the first patient in IGNITE3, the company’s Phase III clinical trial evaluating the efficacy and safety of once-daily…
Cycle Pharmaceuticals to Develop New Vascular Disease Treatment
Cambridge Enterprise has exclusively licensed intellectual property relating to the use of PARP inhibitor drugs for treating vascular disease to Cycle Pharmaceuticals. The University of…
Horizon Broadens Industry-Leading Gene Editing Capabilities
Horizon Discovery Group plc recently announced it has broadened its gene editing capabilities through the amendment of a pre-existing license with ERS Genomics to include…
Dalton Pharma Services Announces Development & Manufacturing Agreement
Dalton Pharma Services recently announced the signing of a drug development and manufacturing services agreement with Cerium Pharmaceuticals, Inc., an emerging biopharmaceutical company based in…
MilliporeSigma Expands End-to-End Biodevelopment Centers
MilliporeSigma, a leading science and technology company, recently announced the expansion of its end-to-end biodevelopment centers to meet increasing customer demand for its turnkey portfolio…
